These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3. Wu Y; Tian L; Xu Y; Zhang M; Xiang S; Zhao J; Wang Z Mol Med Rep; 2018 Aug; 18(2):1644-1650. PubMed ID: 29901083 [TBL] [Abstract][Full Text] [Related]
4. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells. Ma DM; Luo DX; Zhang J World J Surg Oncol; 2016 Oct; 14(1):256. PubMed ID: 27716367 [TBL] [Abstract][Full Text] [Related]
5. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype. Ohmura-Kakutani H; Akiyama K; Maishi N; Ohga N; Hida Y; Kawamoto T; Iida J; Shindoh M; Tsuchiya K; Shinohara N; Hida K PLoS One; 2014; 9(12):e113910. PubMed ID: 25437864 [TBL] [Abstract][Full Text] [Related]
6. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma. Yanagiya M; Dawood RIH; Maishi N; Hida Y; Torii C; Annan DA; Kikuchi H; Yanagawa Matsuda A; Kitamura T; Ohiro Y; Shindoh M; Tanaka S; Kitagawa Y; Hida K Pathol Int; 2021 Jun; 71(6):383-391. PubMed ID: 33783897 [TBL] [Abstract][Full Text] [Related]
7. CXCR7 as a chemokine receptor for SDF-1 promotes gastric cancer progression via MAPK pathways. Shi A; Shi H; Dong L; Xu S; Jia M; Guo X; Wang T Scand J Gastroenterol; 2017; 52(6-7):745-753. PubMed ID: 28281844 [TBL] [Abstract][Full Text] [Related]
8. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment. Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617 [TBL] [Abstract][Full Text] [Related]
9. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells. Qiao N; Wang L; Wang T; Li H Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell. Feng YF; Guo H; Yuan F; Shen MQ PLoS One; 2015; 10(8):e0136175. PubMed ID: 26288180 [TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo. Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519 [TBL] [Abstract][Full Text] [Related]
13. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Miao Z; Luker KE; Summers BC; Berahovich R; Bhojani MS; Rehemtulla A; Kleer CG; Essner JJ; Nasevicius A; Luker GD; Howard MC; Schall TJ Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15735-40. PubMed ID: 17898181 [TBL] [Abstract][Full Text] [Related]
14. CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. Guo JC; Li J; Zhou L; Yang JY; Zhang ZG; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP Oncotarget; 2016 Sep; 7(38):62006-62018. PubMed ID: 27542220 [TBL] [Abstract][Full Text] [Related]
15. CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression. Lin L; Han MM; Wang F; Xu LL; Yu HX; Yang PY Cell Death Dis; 2014 Oct; 5(10):e1488. PubMed ID: 25341042 [TBL] [Abstract][Full Text] [Related]
17. Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity. Spencer HL; Jover E; Cathery W; Avolio E; Rodriguez-Arabaolaza I; Thomas AC; Alvino VV; Sala-Newby G; Dang Z; Fagnano M; Reni C; Rowlinson J; Vono R; Spinetti G; Beltrami AP; Gargioli C; Caporali A; Angelini G; Madeddu P Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1113-1124. PubMed ID: 31018661 [TBL] [Abstract][Full Text] [Related]
18. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer. Nazari A; Khorramdelazad H; Hassanshahi G Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185 [TBL] [Abstract][Full Text] [Related]
19. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice. Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617 [TBL] [Abstract][Full Text] [Related]
20. LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer. Zhao K; Yao Y; Luo X; Lin B; Huang Y; Zhou Y; Li Z; Guo Q; Lu N Carcinogenesis; 2018 Apr; 39(4):588-600. PubMed ID: 29390073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]